Literature DB >> 23430420

Changes in lung function after surgery for mesothelioma.

Till Ploenes1, Thomas Osei-Agyemang, Alexander Krohn, Cornelius F Waller, Viola Duncker-Rohr, Mirjam Elze, Bernward Passlick.   

Abstract

BACKGROUND: The effect of pleurectomy/decortication or extrapleural pleuropneumonectomy on pulmonary function has not yet been evaluated. The aim of this study was to determine the parameters of pulmonary function before and after pleurectomy/decortication or extrapleural pleuropneumonectomy.
METHODS: We conducted a review of 48 patients with unilateral malignant pleural mesothelioma who underwent pleurectomy/decortication or extrapleural pleuropneumonectomy. Data including medical history, histology, survival, and pre- and postoperative pulmonary function were extracted from the medical database of the University Medical Center Freiburg, or sought by telephone interview with the general practitioner or patients.
RESULTS: 25 patients underwent extrapleural pleuropneumonectomy and 23 had pleurectomy/decortication. Pulmonary function was not significantly reduced in the pleurectomy/decortication group postoperatively. In the extrapleural pleuropneumonectomy group, the median preoperative total lung capacity of 4.8 L (77.7%) differed significantly from the postoperative total lung capacity of 3.5 L (55.3%; p <0.0006). The median vital capacity was significantly reduced from 2.8 L (77.7%) preoperatively to 1.8 L (47.6%) postoperatively (p <0.0002). Other parameters were also highly significantly reduced after extrapleural pleuropneumonectomy.
CONCLUSIONS: Pleurectomy/decortication preserved good pulmonary function, whereas extrapleural pleuropneumonectomy significantly reduced pulmonary function, which may lead to dyspnea and influence the quality of life of these patients.

Entities:  

Mesh:

Year:  2013        PMID: 23430420     DOI: 10.1177/0218492312454017

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  11 in total

1.  The impact of surgical approach on quality of life for pleural malignant mesothelioma.

Authors:  Rebecca M Schwartz; Alexis Watson; Andrea Wolf; Raja Flores; Emanuela Taioli
Journal:  Ann Transl Med       Date:  2017-06

2.  Treatment of malignant pleural mesothelioma: lessons learned and quo vadis?

Authors:  Servet Bölükbas; Michael Eberlein
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

3.  Physical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma.

Authors:  Takashi Tanaka; Shinichiro Morishita; Masaki Hashimoto; Yusuke Itani; Satoshi Mabuchi; Norihiko Kodama; Seiki Hasegawa; Kazuhisa Domen
Journal:  Support Care Cancer       Date:  2017-03-14       Impact factor: 3.603

4.  Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis.

Authors:  Till Plönes; Mitja Fischer; Kerstin Höhne; Hiromi Sato; Joachim Müller-Quernheim; Gernot Zissel
Journal:  Pathol Oncol Res       Date:  2017-01-04       Impact factor: 3.201

5.  Depression and Complicated Grief, and Associated Factors, of Bereaved Family Members of Patients Who Died of Malignant Pleural Mesothelioma in Japan.

Authors:  Yasuko Nagamatsu; Yumi Sakyo; Edward Barroga; Riwa Koni; Yuji Natori; Mitsunori Miyashita
Journal:  J Clin Med       Date:  2022-06-13       Impact factor: 4.964

Review 6.  Current surgical strategies for malignant pleural mesothelioma.

Authors:  Teruhisa Takuwa; Seiki Hasegawa
Journal:  Surg Today       Date:  2015-11-21       Impact factor: 2.549

7.  Absence of amplification of the FGFR1-gene in human malignant mesothelioma of the pleura: a pilot study.

Authors:  Till Plönes; Frank Beckers; Walburga Engel-Riedel; Erich Stoelben; Michael Brockmann; Verena Schildgen; Oliver Schildgen
Journal:  BMC Res Notes       Date:  2014-08-19

8.  Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Rebecca M Schwartz; Wil Lieberman-Cribbin; Andrea Wolf; Raja M Flores; Emanuela Taioli
Journal:  BMC Cancer       Date:  2018-11-29       Impact factor: 4.430

9.  Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position.

Authors:  Avijit Datta; Rhiannon Smith; Francesca Fiorentino; Tom Treasure
Journal:  Thorax       Date:  2013-06-12       Impact factor: 9.139

10.  Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).

Authors:  Seiki Hasegawa; Morihito Okada; Fumihiro Tanaka; Takeharu Yamanaka; Toshinori Soejima; Norihiko Kamikonya; Tohru Tsujimura; Kazuya Fukuoka; Kohei Yokoi; Takashi Nakano
Journal:  Int J Clin Oncol       Date:  2015-11-17       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.